F.D.A. Approves Juul Vapes After Yearslong Delay

The U.S. Food and Drug Administration (FDA) has approved the marketing of Juul electronic cigarettes, ending a yearslong delay. Juul, a leading e-cigarette brand, was previously accused of marketing its products to teenagers, leading to a surge in youth vaping. The FDA's decision comes after Juul submitted data demonstrating that its products meet the agency's standards for public health. The approval allows Juul to continue selling its tobacco and menthol-flavored e-cigarettes in the United States. The FDA's decision has been met with criticism from public health advocates who argue that Juul's products have contributed to the youth vaping epidemic. However, the agency stated that the benefits to adult smokers who may use Juul to quit traditional cigarettes outweigh the risks to youth. The approval is a significant development in the ongoing debate surrounding the regulation of e-cigarettes and their potential role in reducing traditional cigarette use while preventing youth addiction.